MRCG/IPPOSI Steering a course to avoid the ‘Drug Iceberg’ – Report V2
[accordionmenu id=\”uniqueba38695\” accordionmenu=\”732\”]
This is the second report from MRCG and IPPOSI on the issue of accessing new and innovative medicines and comes about as a result of a round table meeting hosted in late 2017 with a number of stakeholders from patient organisations, clinicians, industry and the NCPE.
The report from the first meeting of patient organisations alone can be found here
The Drug Iceberg Report V2 (1.30 MB)